BioSpace News Archive

LivaNova PLC announced that Stacy Enxing Seng, a Venture Partner with Lightstone Ventures and former executive at several healthcare and medical technology companies, was elected by the Company’s shareholders to join its Board of Directors during its June 18 annual general meeting.

ScottCare Cardiovascular Solutions announced that it is a winner of the Supplier Horizon Award from Premier Inc., a leading healthcare improvement company.

Seven and Eight Biopharmaceuticals Inc. announced that it has signed a clinical research collaboration agreement with Roche to explore the combination of Seven and Eight’s BDB001, an immune modulator targeting toll-like receptors 7 and 8, and atezolizumab, a monoclonal antibody against the checkpoint target of PD-L1, in treating solid tumors.

After investing more than 100 million U.S. dollars, Sartorius, a leading international partner of biopharmaceutical research and the industry, started up its expanded manufacturing operations in Yauco, Puerto Rico.

An international, randomized Phase 3 study of omidubicel in patients with hematologic malignancies is currently ongoing, and omidubicel has not yet been approved for marketing in the United States or any other jurisdiction.

Funding led by Canaan and Sofinnova Partners To Advance Unique Approach to Immuno-metabolism And Neuro-metabolism.

Ricoh Company, Ltd., (Tokyo, Japan) today announced it has entered into a strategic business partnership with Elixirgen Scientific, Inc., (Baltimore, Maryland, USA), to develop innovative biomedical products and services that support drug discovery based on cell differentiation*1 technology.

At the same time the Japanese MHLW added approval in use of EDTA collection tubes to the existing approval of heparin collection tubes used with this assay.

Metters Was Most Recently CEO of Lycera and Previously Led Worldwide Basic Research for Merck

New Lens is the Most Advanced Soft Contact Lens Design in Bausch + Lomb History